Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Aug;81(2):238–243. doi: 10.1111/j.1365-2249.1990.tb03324.x

Antibody binding and inhibition of pyruvate dehydrogenase (PDH) in sera from patients with primary biliary cirrhosis.

U Sundin 1
PMCID: PMC1535059  PMID: 2387091

Abstract

Autoantibodies reactive against mitochondria which are present in sera from patients with primary biliary cirrhosis (PBC) have been shown to bind to the lipoamide acetyltransferase moiety (E2) of the pyruvate dehydrogenase enzyme complex (PDH). This newly described antigen has been shown to be identical to M2, a 70-kD antigen of the inner mitochondrial membrane. Sera from 10 patients with PBC, 11 patients with chronic active hepatitis (CAH), 20 healthy controls and patients with thyroiditis and systemic lupus erythematosus (SLE) were tested by ELISA for the presence of antibodies (IgG and IgM classes and IgG subclasses) reactive against PDH. The effect of serum and separated IgG and IgM on the PDH enzyme activity was measured spectrophotometrically. Nine out of 10 PBC sera were positive by immunofluorescence for mitochondria (M2 pattern). These nine sera reacted strongly with both IgG and IgM to PDH in the ELISA and also inhibited the enzyme activity by 80% (s.d. 25%). This was significantly different compared with the controls (4 +/- 6%; P less than 0.001). Enzyme inhibition was mainly caused by IgG. Of all control sera (from healthy and patient individuals) only one patient with CAH reacted significantly in the tests. This CAH patient had a high antibody titre against mitochondria as measured by immunofluorescence.

Full text

PDF
238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballardini G., Bianchi F. B., Mirakian R., Fallani M., Pisi E., Bottazzo G. F. HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease. Clin Exp Immunol. 1987 Oct;70(1):35–46. [PMC free article] [PubMed] [Google Scholar]
  2. Beechey R. B., Hubbard S. A., Linnett P. E., Mitchell A. D., Munn E. A. A simple and rapid method for the preparation of adenosine triphosphatase from submitochondrial particles. Biochem J. 1975 Jun;148(3):533–537. doi: 10.1042/bj1480533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Berg P. A., Klein R., Lindenborn-Fotinos J., Klöppel W. ATPase-associated antigen (M2): marker antigen for serological diagnosis of primary biliary cirrhosis. Lancet. 1982 Dec 25;2(8313):1423–1426. doi: 10.1016/s0140-6736(82)91327-7. [DOI] [PubMed] [Google Scholar]
  4. Bird P., Calvert J. E., Mitchison H., Ling N. R., Bassendine M., James O. F. Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture. Clin Exp Immunol. 1988 Mar;71(3):475–480. [PMC free article] [PubMed] [Google Scholar]
  5. Björck L., Kronvall G. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol. 1984 Aug;133(2):969–974. [PubMed] [Google Scholar]
  6. Brüggemann M., Williams G. T., Bindon C. I., Clark M. R., Walker M. R., Jefferis R., Waldmann H., Neuberger M. S. Comparison of the effector functions of human immunoglobulins using a matched set of chimeric antibodies. J Exp Med. 1987 Nov 1;166(5):1351–1361. doi: 10.1084/jem.166.5.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Coppel R. L., McNeilage L. J., Surh C. D., Van de Water J., Spithill T. W., Whittingham S., Gershwin M. E. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7317–7321. doi: 10.1073/pnas.85.19.7317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Frostell A., Mendel-Hartvig I., Nelson B. D., Tötterman T. H., Björkland A., Ragan I. Evidence that the major primary biliary cirrhosis-specific mitochondrial autoantigen is a subunit of complex I of the respiratory chain. Scand J Immunol. 1988 Aug;28(2):157–165. doi: 10.1111/j.1365-3083.1988.tb02427.x. [DOI] [PubMed] [Google Scholar]
  9. Gershwin M. E., Coppel R. L., Mackay I. R. Primary biliary cirrhosis and mitochondrial autoantigens--insights from molecular biology. Hepatology. 1988 Jan-Feb;8(1):147–151. doi: 10.1002/hep.1840080128. [DOI] [PubMed] [Google Scholar]
  10. Hammarström L., Smith C. I. IgG subclass changes in response to vaccination. Monogr Allergy. 1986;19:241–252. [PubMed] [Google Scholar]
  11. Kaplan M. M. Primary biliary cirrhosis. N Engl J Med. 1987 Feb 26;316(9):521–528. doi: 10.1056/NEJM198702263160907. [DOI] [PubMed] [Google Scholar]
  12. Lindenborn-Fotinos J., Sayers T. J., Berg P. A. Mitochondrial antibodies in primary biliary cirrhosis. VI. Association of the complement fixing antigen with a component of the mitochondrial F1-ATPase complex. Clin Exp Immunol. 1982 Nov;50(2):267–274. [PMC free article] [PubMed] [Google Scholar]
  13. Linn T. C., Pelley J. W., Pettit F. H., Hucho F., Randall D. D., Reed L. J. -Keto acid dehydrogenase complexes. XV. Purification and properties of the component enzymes of the pyruvate dehydrogenase complexes from bovine kidney and heart. Arch Biochem Biophys. 1972 Feb;148(2):327–342. doi: 10.1016/0003-9861(72)90151-8. [DOI] [PubMed] [Google Scholar]
  14. Mackay I. R., Gershwin M. E. Molecular basis of mitochondrial autoreactivity in primary biliary cirrhosis. Immunol Today. 1989 Sep;10(9):315–318. doi: 10.1016/0167-5699(89)90088-1. [DOI] [PubMed] [Google Scholar]
  15. Mendel-Hartvig I., Björkland A., Nelson B. D., Norberg R., Ytterström U., Tötterman T. H. Primary biliary cirrhosis: indication for a single mitochondrial antigenic epitope detected by patient autoantibodies and a novel monoclonal antibody. Scand J Immunol. 1988 Oct;28(4):403–410. doi: 10.1111/j.1365-3083.1988.tb01469.x. [DOI] [PubMed] [Google Scholar]
  16. Mendel-Hartvig I., Frostell A., Nelson B. D. Primary biliary cirrhosis: assessment of the quantitative importance of the adenine nucleotide translocator protein as a major mitochondrial antigen. Clin Exp Immunol. 1986 Nov;66(2):399–405. [PMC free article] [PubMed] [Google Scholar]
  17. Mendel-Hartvig I., Nelson B. D., Löf L., Tötterman T. H. Primary biliary cirrhosis: further biochemical and immunological characterization of mitochondrial antigens. Clin Exp Immunol. 1985 Nov;62(2):371–379. [PMC free article] [PubMed] [Google Scholar]
  18. Munoz L. E., Thomas H. C., Scheuer P. J., Doniach D., Sherlock S. Is mitochondrial antibody diagnostic of primary biliary cirrhosis? Gut. 1981 Feb;22(2):136–140. doi: 10.1136/gut.22.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Riggione O., Stokes R. P., Thompson R. A. Predominance of IgG3 subclass in primary cirrhosis. Br Med J (Clin Res Ed) 1983 Mar 26;286(6370):1015–1016. doi: 10.1136/bmj.286.6370.1015-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Schultheiss H. P., Berg P., Klingenberg M. The mitochondrial adenine nucleotide translocator is an antigen in primary biliary cirrhosis. Clin Exp Immunol. 1983 Dec;54(3):648–654. [PMC free article] [PubMed] [Google Scholar]
  21. Smith N. D., Boyer J. L. Are antimitochondrial antibodies of prognostic value in primary biliary cirrhosis? Hepatology. 1986 Jul-Aug;6(4):739–741. doi: 10.1002/hep.1840060433. [DOI] [PubMed] [Google Scholar]
  22. Spengler U., Pape G. R., Hoffmann R. M., Johnson J. P., Eisenburg J., Paumgartner G., Riethmüller G. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology. 1988 May-Jun;8(3):459–462. doi: 10.1002/hep.1840080304. [DOI] [PubMed] [Google Scholar]
  23. Surh C. D., Cooper A. E., Coppel R. L., Leung P., Ahmed A., Dickson R., Gershwin M. E. The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis. Hepatology. 1988 Mar-Apr;8(2):290–295. doi: 10.1002/hep.1840080217. [DOI] [PubMed] [Google Scholar]
  24. Van de Water J., Fregeau D., Davis P., Ansari A., Danner D., Leung P., Coppel R., Gershwin M. E. Autoantibodies of primary biliary cirrhosis recognize dihydrolipoamide acetyltransferase and inhibit enzyme function. J Immunol. 1988 Oct 1;141(7):2321–2324. [PubMed] [Google Scholar]
  25. Van de Water J., Gershwin M. E., Leung P., Ansari A., Coppel R. L. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med. 1988 Jun 1;167(6):1791–1799. doi: 10.1084/jem.167.6.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. WALKER J. G., DONIACH D., ROITT I. M., SHERLOCK S. SEROLOGICAL TESTS IN DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS. Lancet. 1965 Apr 17;1(7390):827–831. doi: 10.1016/s0140-6736(65)91372-3. [DOI] [PubMed] [Google Scholar]
  27. Williamson J. M., Chalmers D. M., Clayden A. D., Dixon M. F., Ruddell W. S., Losowsky M. S. Primary biliary cirrhosis and chronic active hepatitis: an examination of clinical, biochemical, and histopathological features in differential diagnosis. J Clin Pathol. 1985 Sep;38(9):1007–1012. doi: 10.1136/jcp.38.9.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yeaman S. J., Fussey S. P., Danner D. J., James O. F., Mutimer D. J., Bassendine M. F. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet. 1988 May 14;1(8594):1067–1070. doi: 10.1016/s0140-6736(88)91894-6. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES